BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Venzi M, David F, Bellet J, Cavaccini A, Bombardi C, Crunelli V, Di Giovanni G. Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures. Neuropharmacology 2016;108:292-304. [PMID: 27085605 DOI: 10.1016/j.neuropharm.2016.04.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Delicata F, Bombardi C, Pierucci M, Di Maio R, De Deurwaerdère P, Di Giovanni G. Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence. CNS Neurosci Ther 2018;24:721-33. [PMID: 29479825 DOI: 10.1111/cns.12830] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
2 Das A, Zhu B, Xie Y, Zeng L, Pham AT, Neumann JC, Safrina O, Benavides DR, MacGregor GR, Schutte SS, Hunt RF, O'Dowd DK. Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS. eNeuro 2021;8:ENEURO. [PMID: 33658306 DOI: 10.1523/ENEURO.0394-20.2021] [Reference Citation Analysis]
3 Higgins GA, Silenieks LB, Patrick A, De Lannoy IAM, Fletcher PJ, Parker LA, MacLusky NJ, Sullivan LC, Chavera TA, Berg KA. Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101. ACS Chem Neurosci 2017;8:1074-84. [PMID: 28338324 DOI: 10.1021/acschemneuro.6b00444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
4 Colangeli R, Teskey GC, Di Giovanni G. Endocannabinoid-serotonin systems interaction in health and disease. Prog Brain Res 2021;259:83-134. [PMID: 33541682 DOI: 10.1016/bs.pbr.2021.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Massey CA, Thompson SJ, Ostrom RW, Drabek J, Sveinsson OA, Tomson T, Haas EA, Mena OJ, Goldman AM, Noebels JL. X-linked serotonin 2C receptor is associated with a non-canonical pathway for sudden unexpected death in epilepsy. Brain Commun 2021;3:fcab149. [PMID: 34396109 DOI: 10.1093/braincomms/fcab149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vincentiis S, Alcantara JA, Rzezak P, Kerr DS, Gattaz WF, van der Linden H Jr, Dos Santos B, Arruda F, Chaim-Avancini T, Serpa MH, Fernandes F, Moreno RA, Busatto GF, Alessi R, Demarque R, Valente KD. Genetic polymorphisms of the serotonin transporter are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis. Epilepsy Behav 2021;117:107854. [PMID: 33639436 DOI: 10.1016/j.yebeh.2021.107854] [Reference Citation Analysis]
7 Sere P, Zsigri N, Raffai T, Furdan S, Győri F, Crunelli V, Lőrincz ML. Activity of the Lateral Hypothalamus during Genetically Determined Absence Seizures. Int J Mol Sci 2021;22:9466. [PMID: 34502374 DOI: 10.3390/ijms22179466] [Reference Citation Analysis]
8 Akyuz E, Doganyigit Z, Paudel YN, Koklu B, Kaymak E, Villa C, Arulsamy A, Shaikh MF, Devinsky O. Immunoreactivity of Muscarinic Acetylcholine M2 and Serotonin 5-HT2B Receptors, Norepinephrine Transporter and Kir Channels in a Model of Epilepsy. Life (Basel) 2021;11:276. [PMID: 33810231 DOI: 10.3390/life11040276] [Reference Citation Analysis]
9 Aygun H. Trazodone increases seizures in a genetic WAG/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model. Epilepsy Behav 2020;103:106847. [PMID: 31864946 DOI: 10.1016/j.yebeh.2019.106847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lin Z, Smith MD, Concepcion GP, Haygood MG, Olivera BM, Light A, Schmidt EW. Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products. J Nat Prod 2017;80:2360-70. [PMID: 28745513 DOI: 10.1021/acs.jnatprod.7b00317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Saraf TS, Felsing DE, Armstrong JL, Booth RG, Canal CE. Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice. Epilepsy Res 2021;175:106677. [PMID: 34130255 DOI: 10.1016/j.eplepsyres.2021.106677] [Reference Citation Analysis]
12 Taskiran M, Tasdemir A, Ayyildiz N, Ayyildiz M, Agar E. The effect of serotonin on penicillin-induced epileptiform activity. International Journal of Neuroscience 2019;129:687-97. [DOI: 10.1080/00207454.2018.1557166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ziobro J, Eschbach K, Sullivan JE, Knupp KG. Current Treatment Strategies and Future Treatment Options for Dravet Syndrome. Curr Treat Options Neurol 2018;20:52. [PMID: 30315507 DOI: 10.1007/s11940-018-0537-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
14 David F, Çarçak N, Furdan S, Onat F, Gould T, Mészáros Á, Di Giovanni G, Hernández VM, Chan CS, Lőrincz ML, Crunelli V. Suppression of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Function in Thalamocortical Neurons Prevents Genetically Determined and Pharmacologically Induced Absence Seizures. J Neurosci 2018;38:6615-27. [PMID: 29925625 DOI: 10.1523/JNEUROSCI.0896-17.2018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Silenieks LB, Carroll NK, Van Niekerk A, Van Niekerk E, Taylor C, Upton N, Higgins GA. Evaluation of Selective 5-HT2C Agonists in Acute Seizure Models. ACS Chem Neurosci 2019;10:3284-95. [PMID: 31082204 DOI: 10.1021/acschemneuro.8b00739] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
16 Bombardi C, Delicata F, Tagliavia C, Pierucci M, Deidda G, Casarrubea M, De Deurwaerdère P, Di Giovanni G. Acute and Chronic Nicotine Exposures Differentially Affect Central Serotonin 2A Receptor Function: Focus on the Lateral Habenula. Int J Mol Sci 2020;21:E1873. [PMID: 32182934 DOI: 10.3390/ijms21051873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Cassar D, Radic M, Casarrubea M, Crunelli V, Di Giovanni G. The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze. CNS Neurosci Ther 2022. [PMID: 35470960 DOI: 10.1111/cns.13848] [Reference Citation Analysis]
18 Higgins GA, Fletcher PJ, Shanahan WR. Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential. Pharmacology & Therapeutics 2020;205:107417. [DOI: 10.1016/j.pharmthera.2019.107417] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
19 Crunelli V, Lőrincz ML, McCafferty C, Lambert RC, Leresche N, Di Giovanni G, David F. Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures. Brain 2020;143:2341-68. [PMID: 32437558 DOI: 10.1093/brain/awaa072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
20 de Freitas RL, Medeiros P, da Silva JA, de Oliveira RC, de Oliveira R, Ullah F, Khan AU, Coimbra NC. The μ1-opioid receptor and 5-HT2A- and 5HT2C-serotonergic receptors of the locus coeruleus are critical in elaborating hypoalgesia induced by tonic and tonic–clonic seizures. Neuroscience 2016;336:133-45. [DOI: 10.1016/j.neuroscience.2016.08.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
21 Vieira ÉLM, da Silva MCM, Gonçalves AP, Martins GL, Teixeira AL, de Oliveira ACP, Reis HJ. Serotonin and dopamine receptors profile on peripheral immune cells from patients with temporal lobe epilepsy. J Neuroimmunol 2021;354:577534. [PMID: 33713941 DOI: 10.1016/j.jneuroim.2021.577534] [Reference Citation Analysis]
22 Deidda G, Crunelli V, Di Giovanni G. 5-HT/GABA interaction in epilepsy. Prog Brain Res 2021;259:265-86. [PMID: 33541679 DOI: 10.1016/bs.pbr.2021.01.008] [Reference Citation Analysis]
23 Ethemoglu MS, Kutlu S, Seker FB, Erdogan CS, Bingol CA, Yilmaz B. Effects of agomelatine on electrocorticogram activity on penicillin-induced seizure model of rats. Neurosci Lett 2019;690:120-5. [PMID: 30213622 DOI: 10.1016/j.neulet.2018.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Tolete P, Knupp K, Karlovich M, DeCarlo E, Bluvstein J, Conway E, Friedman D, Dugan P, Devinsky O. Lorcaserin therapy for severe epilepsy of childhood onset: A case series. Neurology 2018;91:837-9. [PMID: 30258026 DOI: 10.1212/WNL.0000000000006432] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
25 De Deurwaerdère P, Ramos M, Bharatiya R, Puginier E, Chagraoui A, Manem J, Cuboni E, Pierucci M, Deidda G, Casarrubea M, Di Giovanni G. Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats. Neuropharmacology 2020;166:107915. [PMID: 31862271 DOI: 10.1016/j.neuropharm.2019.107915] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
26 Svob Strac D, Pivac N, Smolders IJ, Fogel WA, De Deurwaerdere P, Di Giovanni G. Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs. Front Neurosci 2016;10:492. [PMID: 27891070 DOI: 10.3389/fnins.2016.00492] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
27 Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev 2021;73:310-520. [PMID: 33370241 DOI: 10.1124/pr.118.015552] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
28 Bialer M, Perucca E. Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine? CNS Drugs. [DOI: 10.1007/s40263-022-00896-3] [Reference Citation Analysis]
29 Di Giovanni G, De Deurwaerdère P. TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above? Neuropharmacology 2018;142:20-9. [PMID: 28987938 DOI: 10.1016/j.neuropharm.2017.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
30 Kilinc E, Torun IE, Cetinkaya A, Tore F. Mast cell activation ameliorates pentylenetetrazole-induced seizures in rats: The potential role for serotonin. Eur J Neurosci 2021. [PMID: 33565644 DOI: 10.1111/ejn.15145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 De Deurwaerdère P, Casarrubea M, Cassar D, Radic M, Puginier E, Chagraoui A, Crescimanno G, Crunelli V, Di Giovanni G. Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats. Front Cell Neurosci 2022;16:886033. [DOI: 10.3389/fncel.2022.886033] [Reference Citation Analysis]
32 Palacios JM, Pazos A, Hoyer D. A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment. Psychopharmacology (Berl) 2017;234:1395-418. [PMID: 28265714 DOI: 10.1007/s00213-017-4545-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
33 De Deurwaerdère P, Bharatiya R, Chagraoui A, Di Giovanni G. Constitutive activity of 5-HT receptors: Factual analysis. Neuropharmacology 2020;168:107967. [DOI: 10.1016/j.neuropharm.2020.107967] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
34 Schwitalla JC, Pakusch J, Mücher B, Brückner A, Depke DA, Fenzl T, De Zeeuw CI, Kros L, Hoebeek FE, Mark MD. Controlling absence seizures from the cerebellar nuclei via activation of the Gq signaling pathway. Cell Mol Life Sci 2022;79:197. [PMID: 35305155 DOI: 10.1007/s00018-022-04221-5] [Reference Citation Analysis]
35 Di Giovanni G, Chagraoui A, Bharatiya R, De Deurwaerdère P. Serotonergic control of excitability: from neuron to networks. Handbook of the Behavioral Neurobiology of Serotonin. Elsevier; 2020. pp. 197-215. [DOI: 10.1016/b978-0-444-64125-0.00010-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ramsay RR, De Deurwaerdère P, Di Giovanni G. Updating neuropathology and neuropharmacology of monoaminergic systems. Br J Pharmacol 2016;173:2065-8. [PMID: 27302283 DOI: 10.1111/bph.13508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Di Maio R, Colangeli R, Di Giovanni G. WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT2C/NMDA/CB1 Receptors in the Rat Hippocampus. ACS Chem Neurosci 2019;10:3296-306. [PMID: 30912644 DOI: 10.1021/acschemneuro.9b00080] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
38 Di Giovanni G, Bharatiya R, Puginier E, Ramos M, De Deurwaerdère S, Chagraoui A, De Deurwaerdère P. Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain. Front Pharmacol 2020;11:962. [PMID: 32714188 DOI: 10.3389/fphar.2020.00962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Colangeli R, Di Maio R, Pierucci M, Deidda G, Casarrubea M, Di Giovanni G. Synergistic action of CB1 and 5-HT2B receptors in preventing pilocarpine-induced status epilepticus in rats. Neurobiol Dis 2019;125:135-45. [PMID: 30716469 DOI: 10.1016/j.nbd.2019.01.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]